India Diabetes Devices Market Size
| Study Period | 2018 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| Market Size (2024) | USD 2.20 Billion |
| Market Size (2029) | USD 2.46 Billion |
| CAGR (2024 - 2029) | 2.28 % |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Need a report that reflects how COVID-19 has impacted this market and its growth?
India Diabetes Devices Market Analysis
The India Diabetes Devices Market size is estimated at USD 2.20 billion in 2024, and is expected to reach USD 2.46 billion by 2029, growing at a CAGR of 2.28% during the forecast period (2024-2029).
According to the Article Published in 'THE HINDU' One in six people with diabetes in the world is from India. The numbers place the country among the top 10 countries for people with diabetes, coming in at number two with an estimated 80 million diabetics. Over half of the population in India is at risk of having diabetes at some time in their life, making the disease a significant public health problem. A rise in type 2 diabetes incidence is also being seen in India's rural areas.
High blood sugar levels are a hallmark of the metabolic disorder diabetes mellitus, also known as diabetes. Type 1 diabetes or insulin-dependent diabetes mellitus is caused by a complete lack of insulin. Type 2 diabetes mellitus is a condition where the body does not produce enough insulin, or the body cannot utilize the insulin it produces. Type 2 diabetes is said to be a lifestyle disease. The consumption of sugary sweets is a staple of Indian culture and an integral part of ancient traditions and religious festivals.
Diabetes care devices are devices used to monitor the glucose levels in the blood. The main types of diabetes care devices include glucose monitoring devices and management devices. Continuous glucose monitoring devices have become immensely popular due to the rise in technological innovations. India holds the second-largest market in the diabetes care devices market after China in the Asia-Pacific region, because of the increasing diabetes population in the country. The diabetes population in India is expected to reach 92 million by 2027.
Thus, owing to the above factors it is expected to drive the market growth over the forecast period.
India Diabetes Devices Market Trends
Increasing use of monitoring devices in India
In India, the monitoring devices segment is expected to increase with a CAGR of over 7% during the forecast period, mainly due to the demand from the Type-1 diabetes population, which was more than 9 million by the end of the forecast period.
Monitoring devices include self-monitoring blood glucose (SMBG) and continuous glucose monitoring devices (CGM). The SMBG segment held a major share of the Indian diabetes devices market and generated revenue of USD 130.53 million in the current year. The frequency of monitoring glucose levels depends on the type of diabetes, which varies from patient to patient. The awareness of self-monitoring of glucose levels has increased widely in India, and the market for monitoring devices is expected to register high growth in the country with a CAGR of 10% during the forecast period. Type-1 diabetic patients need to check their blood glucose levels at regular intervals to adjust their insulin dosing accordingly.
The current CGM devices reduce finger pricking for measuring blood glucose levels. It shows a more detailed representation of blood glucose patterns and tendencies than can be achieved by conventional routine checking of glucose levels at set intervals.
Thus, owing to the above factors, it is expected to drive market growth over the forecast period.
India recorded the second-highest diabetes population in Asia-Pacific
In India, there are currently 80.52 million people suffering from diabetes, and by 2027, nearly 10% of India's population is likely to be affected by diabetes. Obesity, especially central obesity, increased visceral fat due to physical inactivity, and consumption of high-calorie, high-fat, and high-sugar diets are the major contributing factors to diabetes in Indians. The most prominent work culture perpetuated in the country, which includes sitting for hours in one position and eating fast food with little or no physical activity, is a significant contributor to diabetes in the working-age group, causing this rapid increase in diabetes cases in India.
In India, the International Diabetes Federation (IDF) estimates that 10% of global health expenditure is spent on diabetes. According to the Ministry of Health and Family Welfare of the Government of India, out of all deaths in India, 60% are related to non-communicable diseases (NCDs). Non-communicable diseases like diabetes, cardiovascular diseases, cancer, chronic respiratory diseases, etc. In order to prevent and control major NCDs, the National Program for Prevention and Control of Cancer, Diabetes, Cardiovascular Diseases, and Stroke (NPCDCS) includes medical education, health awareness in schools, and urban planning for diabetes.
Thus, owing to the above factors, it is expected to drive market growth over the forecast period.
India Diabetes Devices Industry Overview
The Indian diabetes care device market is dominated by a few major players. In the CGM market in India, there are only a few players that occupy a major share of the market. However, in the SMBG market, the number of players is high and includes several local players.
India Diabetes Devices Market Leaders
-
Medtronics
-
Becton Dickinson
-
Roche
-
Dexcom
-
Abbott
*Disclaimer: Major Players sorted in no particular order
India Diabetes Devices Market News
- November 2023: Terumo India, the Indian subsidiary of Terumo Corporation, a renowned player in the field of medical technology, unveiled today the introduction of the Insulin Syringe, a sterile delivery tool designed for patients in need of frequent insulin injections. This move sets a new standard in enhancing patient comfort and adherence to therapy.
- March 2022: Medtronic India launched the MiniMed 780G, a next-generation closed-loop insulin pump system. The MiniMed 780G system is a next-generation closed-loop insulin pump system for the treatment of type-1 diabetes in people aged 7-80 years.
India Diabetes Devices Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Assumptions and Market Definition
- 1.2 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
- 4.2 Market Drivers
- 4.3 Market Restraints
-
4.4 Industry Attractiveness - Porter's Five Forces Analysis
- 4.4.1 Bargaining Power of Buyers/Consumers
- 4.4.2 Bargaining Power of Suppliers
- 4.4.3 Threat of New Entrants
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Monitoring Devices
- 5.1.1 Self-monitoring Blood Glucose Devices
- 5.1.1.1 Glucometer Devices
- 5.1.1.2 Test Strips
- 5.1.1.3 Lancets
- 5.1.2 Continuous Blood Glucose Monitoring
- 5.1.2.1 Sensors
- 5.1.2.2 Durables
-
5.2 Management Devices
- 5.2.1 Insulin Pump
- 5.2.1.1 Insulin Pump Device
- 5.2.1.2 Insulin Pump Reservoir
- 5.2.1.3 Infusion Set
- 5.2.2 Insulin Syringes
- 5.2.3 Insulin Cartridges
- 5.2.4 Disposable Pens
6. MARKET INDICATORS
- 6.1 Type-1 Diabetes Population
- 6.2 Type-2 Diabetes Population
7. COMPETITIVE LANDSCAPE
-
7.1 Company Profiles
- 7.1.1 Becton and Dickenson
- 7.1.2 Medtronic
- 7.1.3 Insulet
- 7.1.4 Tandem
- 7.1.5 Ypsomed
- 7.1.6 Novo Nordisk
- 7.1.7 Sanofi
- 7.1.8 Eli Lilly
- 7.1.9 Abbottt
- 7.1.10 Roche
- 7.1.11 Lifescan (Johnson &Johnson)
- 7.1.12 Dexcom
- *List Not Exhaustive
- 7.2 Company Share Analysis
8. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityIndia Diabetes Devices Industry Segmentation
Diabetes devices help monitor and manage blood glucose levels. Diabetes patients using diabetes devices can significantly improve their health. The Indian diabetes care device market is segmented into monitoring devices and management devices. The report offers the value (in USD) and volume (in units) for the above segments.
| Monitoring Devices | Self-monitoring Blood Glucose Devices | Glucometer Devices |
| Test Strips | ||
| Lancets | ||
| Monitoring Devices | Continuous Blood Glucose Monitoring | Sensors |
| Durables | ||
| Management Devices | Insulin Pump | Insulin Pump Device |
| Insulin Pump Reservoir | ||
| Infusion Set | ||
| Management Devices | Insulin Syringes | |
| Insulin Cartridges | ||
| Disposable Pens |
India Diabetes Devices Market Research FAQs
How big is the India Diabetes Devices Market?
The India Diabetes Devices Market size is expected to reach USD 2.20 billion in 2024 and grow at a CAGR of 2.28% to reach USD 2.46 billion by 2029.
What is the current India Diabetes Devices Market size?
In 2024, the India Diabetes Devices Market size is expected to reach USD 2.20 billion.
Who are the key players in India Diabetes Devices Market?
Medtronics, Becton Dickinson, Roche, Dexcom and Abbott are the major companies operating in the India Diabetes Devices Market.
What years does this India Diabetes Devices Market cover, and what was the market size in 2023?
In 2023, the India Diabetes Devices Market size was estimated at USD 2.15 billion. The report covers the India Diabetes Devices Market historical market size for years: 2018, 2019, 2020, 2021, 2022 and 2023. The report also forecasts the India Diabetes Devices Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
India Diabetes Devices Industry Report
Statistics for the 2024 India Diabetes Devices market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. India Diabetes Devices analysis includes a market forecast outlook to for 2024 to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
